Synthesis of methylene-expanded oxetanocin isonucleosides in both enantiomeric forms

Journal of Organic Chemistry

Volumn 63, Issue 2, 1998, Pages 347-355

  Jung, Michael E ^a   Nichols, Christopher J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OXETANOCIN A; OXETANOCIN DERIVATIVE; OXETANOCIN G;

ACETYLATION; ANTIVIRAL ACTIVITY; ARTICLE; CYCLIZATION; CYTOTOXICITY; DNA SYNTHESIS INHIBITION; DRUG SYNTHESIS; ENANTIOMER; EPOXIDATION; NONHUMAN;

EID: 0032559322     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo971890c     Document Type: Article

References (37)

1. (a) Shimada, N.; Hasegawa, S.; Harada, T.; Tomisawa, T.; Fujii, A.; Takita, T. J. Antibiot. 1986, 39, 1623.
2. (b) Nakamura, H.; Hasegawa, S.; Shimada, N.; Fujii, A.; Takita, T.; Iitaka, Y. J. Antibiot. 1986, 39, 1626.
3. (c) Wilson, F. X.; Fleet, G. W. J.; Vogt, K.; Wang, Y.; Witty, D. R.; Choi, S.; Storer, R.; Myers, P. L.; Wallis, C. J. Tetrahedron Lett. 1990, 31, 6931.
4. (d) Norbeck, D. W.; Kramer, J. B. J. Am. Chem. Soc. 1988, 110, 7217.
5. (e) Niitsuma, S.; Ichikawa, Y.-i.; Kato, K.; Takita, T. Tetrahedron Lett. 1987, 28, 3967.
6. (f) Nishiyama, S.; Yamamura, S.; Kato, K.; Takita, T. Tetrahedron Lett. 1988, 29, 4739.
7. (g) Hambalek, R.; Just, G. Tetrahedron Lett. 1990, 31, 5445.
8. Slusarchyk, W. A.; Young, M. G.; Bisacchi, G. S.; Hockstein, D. R.; Zahler, R. Tetrahedron Lett. 1989, 30, 6453.
9. Hosono, F.; Nishiyama, S.; Tamamura, S.; Izawa, T.; Kato, K.; Terada, Y. Tetrahedron 1994, 50, 13335.
10. (a) Tino, J. A.; Clark, J. M.; Field, A. K.; Jacobs, G. A.; Lis, K. A.; Michalik, T. L.; McGreever-Rubin, B.; Slusarchyk, W. A.; Spergel, S. H.; Sundeen, J. E.; Tuomari, A. V.; Weaver, E. R.; Young, M. G.; Zahler, R. J. Med. Chem. 1993, 36, 1221.
11. (b) Kakefuda, A.; Shuto, S.; Nagahata, T.; Seki, J.-i.; Sasaki, T.; Matsuda, A. Tetrahedron 1994, 50, 10167.
12. (c) For an example of a structurally similar compound, the cyclopentene analogue in the L-series, with good anti-HIV activity, see: Katagiri, N.; Shiraishi, T.; Sato, H.; Toyota, A.; Kaneko, C.; Yusa, K.; Oh-hara, T.; Tsuruo, T. Biochem. Biophys. Res. Commun. 1992, 184, 154. Katagiri, N.; Shiraishi, T.; Toyota, A.; Sato, H.; Kaneko, C.; Aikawa, T. Chem. Pharm. Bull. 1993, 41, 1027.
13. (c) For an example of a structurally similar compound, the cyclopentene analogue in the L-series, with good anti-HIV activity, see: Katagiri, N.; Shiraishi, T.; Sato, H.; Toyota, A.; Kaneko, C.; Yusa, K.; Oh-hara, T.; Tsuruo, T. Biochem. Biophys. Res. Commun. 1992, 184, 154. Katagiri, N.; Shiraishi, T.; Toyota, A.; Sato, H.; Kaneko, C.; Aikawa, T. Chem. Pharm. Bull. 1993, 41, 1027.
14. (a) Chang, C.-N.; Doong, S.-L.; Zhou, J. H.; Beach, J. W.; Jeong, L. S.; Chu, C. K; Tsai, C.-h.; Cheng, Y.-c. J. Biol. Chem. 1992, 267, 13938.
15. (b) Chang, C.-N.; Skalski, V.; Zhou, J. H.; Cheng, Y.-c. J. Biol. Chem. 1992, 267, 22414.
16. (c) Beach, J. W.; Jeong, L. S.; Alves, A. J.; Pohl, D.; Kim, H. O.; Chang, C.-N.; Coong, S.-L.; Schinazi, R. F.; Cheng, Y.-C.; Chu, C. K. J. Org. Chem. 1992, 57, 2217.
17. (d) Coates, J. A. V.; Cammack, N.; Jenkinson, H. J.; Mutton, I. M.; Pearson, B. A.; Storer, R.; Cameron, J. M.; Penn, C. R. Antimicrob. Agents Chemother. 1992, 36, 202.
18. (e) Schinazi, R. F.; Chu, C. K.; Peck, A.; McMillan, A.; Mathis, R.; Cannon, D.; Jeong, L.-S.; Beach, J. W.; Choi, W.-B.; Yeola, S.; Liotta, D. C. Antimicrob. Agents Chemother. 1992, 36, 672.
19. (a) Hoong, L. K.; Strange, L. E.; Liotta, D. C.; Koszalka, G. W.; Burns, C. L.; Schinazi, R. F. J. Org. Chem. 1992, 57, 5563.
20. (b) Furman, P. A.; Davis, M.; Liotta, D. C.; Paff, M.; Frick, L. W.; Nelson, D. J.; Dornsife, R. E.; Wurster, J. A.; Wilson, L. J.; Fyfe, J. A.; Tuttle, J. V.; Miller, W. H.; Conderay, L.; Averett, D. R.; Schinazi, R. F.; Painter, G. R. Antimicrob. Agents Chemother. 1992, 36, 2686.
21. (a) Mansuri, M. M.; Farina, V.; Starrett, J. E., Jr.; Benigni, D. A.; Brankovan, V.; Martin, J. C. Bioorg. Med. Chem. Lett. 1991, 1, 65.
22. (b) Lin, T.-S.; Luo, M.-Z.; Liu, M.-C.; Pai, B.; Dutschman, G. E.; Cheng, Y.-C. J. Med. Chem. 1994, 37, 798.
23. (c) Gosselin, G.; Schinazi, R. F.; Sommadossi, J.-P.; Mathé, C.; Bergogne, M.-C.; Aubertin, A.-M.; Kirn, A.; Imbach, J.-L. Antimicrob. Agents Chemother. 1994, 38, 1292.
24. For a discussion of our approach to the oxetanocins, see: Jung, M. E.; Nichols, C. J. Tetrahedron Lett. 1996, 37, 7667.
25. (a) Svansson, L.; Kvarnström, I.; Classen, B.; Samuelsson. B. J. Org. Chem. 1991, 56, 2993.
26. (b) Chong, J. M.; Wong, S. J. Org. Chem. 1987, 52, 2596.
27. Tius, M. A.; Fauq, A. H. J. Org. Chem. 1983, 48, 4131.
28. Evans, R. D.; Magee, J. W.; Schauble, J. H. Synthesis 1988, 862.
29. Rychnovsky, S. D.; Bartlett, P. A. J. Am. Chem. Soc. 1981, 103, 3963.
30. (a) Amouroux, R.; Gerin, B.; Chastrette, M. Tetrahedron Lett. 1982, 23, 4341.
31. (b) Hatakeyama, S.; Sakurai, K.; Takano, S. Heterocycles 1986, 24, 633.
32. We have observed this greatly reduced reactivity of alkyl halides with electron-withdrawing groups in the β- or even γ-position several times; for an example, see: Jung, M. E.; Parker, M. H. J. Org. Chem. 1997, 62, 7094. Parker, M. H. Ph.D. Thesis, UCLA, 1997.
33. We have observed this greatly reduced reactivity of alkyl halides with electron-withdrawing groups in the β- or even γ-position several times; for an example, see: Jung, M. E.; Parker, M. H. J. Org. Chem. 1997, 62, 7094. Parker, M. H. Ph.D. Thesis, UCLA, 1997.
34. Vaino, A. R.; Szarek, W. A. Chem. Commun. 1996, 2351.
35. (a) For a novel synthesis of L-ribose and 2-deoxy-L-ribose from D-ribose and L-arabinose, see: Jung, M. E.; Xu, Y. Tetrahedron Lett. 1997, 38, 4199.
36. (b) We have also developed a de novo synthesis of 2-deoxy-L-ribose: Jung, M. E.; Nichols, C. J. Manuscript in preparation.
37. Alexakis, A.; Mutti, S.; Normant, J. F.; Mangeney, P. Tetrahedron Asym. 1990, 1, 437.